Dr. Park, Assistant Professor in the Department of Bioengineering at CU Denver, receives NIH R21 grant

Dr. Park, Assistant Professor in the Department of Bioengineering at CU Denver, receives NIH R21 grant ($406,500) from National Heart, Lung, and Blood Institute. His project title is “A biomimetic reverse thermal gel for the treatment of myocardial infarction”. NIH will support this research for two years.

Myocardial infarction (MI) is a leading coronary artery disease caused by the death of heart muscle tissues. The aim of this research is to develop new methodology to treat MI using a synthetic growth factor (GF) delivery system that 1) mimics biofunction of natural heparin, 2) achieves sustained and localized GF expression and 3) promotes angiogenesis in the infarction site and thereby enhances MI treatment effect.

Dr. Park receives CU Technology Transfer State Bioscience Award

The University of Colorado Technology Transfer Office (TTO) has awarded Daewon Park, Ph.D., an Assistant Professor in the Department of Bioengineering, a State Bioscience Proof of Concept Grant (POCsb) for his proposal to further develop the technology identified to the TTO as Antimicrobial reverse thermal gel for surgical coating.

This proposal aims at developing a polymer-based antimicrobial surgical coating that can act as a surgical incision drape. This polymer is specifically designed to possess a reverse thermal gelling property. It is a water-soluble material and maintains its solution state at low temperature whilst turning into a physical gel upon heating (e.g. upon contact of human skin). This unique property allows the product to be easily sprayed on the patient’s skin and form a layer of antimicrobial gel on the skin surface. During the surgery the gel might dry out and form a film on the skin; however, the film will maintain its antimicrobial activity during the entire surgical process. Moreover, since the polymer returns to solution state at low temperature, it can be easily removed by washing with cold water (or cold alcohol) without the risk of epidermal cell layer detachment. Some may worry that the gel may be solubilized during the surgery by body fluid (e.g., blood); however, once the gel is formed, it only returns to a liquid state in a low temperature environment (<~15oC).

Bioengineering PhD candidate, Gregory Futia, has been awarded a TL1 predoctoral training fellowship by the CCTSI

??????????????????????????????????Gregory Futia, a PhD candidate in the department of bioengineering, has been awarded a TL1 predoctoral training fellowship by the Colorado Clinical and Translational Sciences Institute for project titled, “Investigations of Lipid Content and Quantitate Microscopy for the Identification of Circulating Tumor Cells(CTC) from Ovarian Carcinoma”.

Greg is pursuing this project is under the mentorship of Emily Gibson PhD, faculty member in the Department of Bioengineeirng, and Kian Behbakht MD, clinician and faculty member in the Department Obstetrics and Oncology.

Through this fellowship, Greg will be exposed to the difficulties encountered in clinical trial design and the short coming of current disease monitoring end points. Overall, this fellowship will further develop Greg’s expertise in the clinical and translational aspects of his research.


Stapleton study reveals problems with new urbanism development

Kathleen Lavine, Business Journal

A newly released University of Colorado Denver study found that Stapleton has struggled to adjust to the need for infrastructure centered around more sustainable, walkable communities and has fallen behind neighboring Denver communities.

Read the full story in the Denver Business Journal

Yakacki, Shandas receive CU Denver | Anschutz Medical Campus Technology Transfer Awards

Congratulations to Chris Yakacki, mechanical engineering, and Robin Shandas, bioengineering, for receiving CU Denver | Anschutz Technology Transfer Awards. Chris was awarded “New Inventor of the Year,” while EndoShape, Inc., a company based on work by Robin, was awarded the “CU Denver | Anschutz Company of the Year.”

The entire press release is below.

Continue reading

Tanya Evans, predoctoral trainee in the Department of Bioengineering, granted an NHLBI Graduate Research Supplement

Evans, Tanya

Tanya Evans, a predoctoral trainee in the Department of Bioengineering at CU Denver, is a recipient of a National Heart, Lung, and Blood Institute (NHLBI) Graduate Research Supplement. Tanya is receiving the award as part of a parent grant with her advisor, Dr. Robin Shandas.

The research supplements are available to students of active National Institutes of Health (NIH) research grantees. The supplements were designed to increase diversity in health-related research by supporting and recruiting students from underrepresented groups.

The NHLBI provides research, training, and education to promote the prevention and treatment of heart, lung, and blood diseases. The NHLBI has a history of fostering training and mentoring of emerging scientists. It has forged robust partnerships with private and public organizations, including academia, industry, and other government agencies.

This research supplement will continue to support Tanya in her work to improve ultrasound imaging techniques for accurate assessment of cardiovascular functioning.